Nuvectis Pharma, Inc. NVCT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -154.4%-39.1pp | -188%-14.6pp | -145%-5.0pp | -150.1%-21.7pp | -115.3%+54.9pp | |
| Liquidity | ||||||
| Current ratio | 2.3×-1.0× | 2.4×+0.3× | 3.1×+0.3× | 2.7×-0.5× | 3.3×-0.2× | |
| Per Share | ||||||
| Book value per share | $0.61-42.2% | $0.84+48.7% | $1.06+65.7% | $0.79+6.5% | $1.05+24.1% | |
| Valuation | ||||||
| Market capitalization | $739.27M+335% | $193.39M+85.0% | $153.25M+44.2% | $166.73M+59.1% | $228.53M+68.3% | |
| Price / book | 52×+43.9× | 10.5×-0.3× | 6.4×-3.3× | 9.9×+1.5× | 10.9×+1.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Nuvectis Pharma, Inc.'s ratios come from?
- Every ratio is computed from Nuvectis Pharma, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.